- Home
- LPCN vs AEHL Comparison
LPCN vs AEHL Comparison
Compare LPCN & AEHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- AEHL
- Stock Information
- Founded
- LPCN 1997
- AEHL 1993
- Country
- LPCN United States
- AEHL China
- Employees
- LPCN N/A
- AEHL N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- AEHL Building Materials
- Sector
- LPCN Health Care
- AEHL Industrials
- Exchange
- LPCN Nasdaq
- AEHL Nasdaq
- Market Cap
- LPCN 16.1M
- AEHL 13.9M
- IPO Year
- LPCN N/A
- AEHL 2007
- Fundamental
- Price
- LPCN $2.95
- AEHL $2.07
- Analyst Decision
- LPCN Strong Buy
- AEHL
- Analyst Count
- LPCN 2
- AEHL 0
- Target Price
- LPCN $9.00
- AEHL N/A
- AVG Volume (30 Days)
- LPCN 36.3K
- AEHL 634.3K
- Earning Date
- LPCN 08-05-2025
- AEHL 09-29-2025
- Dividend Yield
- LPCN N/A
- AEHL N/A
- EPS Growth
- LPCN N/A
- AEHL N/A
- EPS
- LPCN N/A
- AEHL N/A
- Revenue
- LPCN $4,208,119.00
- AEHL $98,773,000.00
- Revenue This Year
- LPCN N/A
- AEHL N/A
- Revenue Next Year
- LPCN N/A
- AEHL N/A
- P/E Ratio
- LPCN N/A
- AEHL N/A
- Revenue Growth
- LPCN N/A
- AEHL 36.99
- 52 Week Low
- LPCN $2.68
- AEHL $1.79
- 52 Week High
- LPCN $6.17
- AEHL $167.60
- Technical
- Relative Strength Index (RSI)
- LPCN 37.54
- AEHL 25.65
- Support Level
- LPCN $2.92
- AEHL $3.02
- Resistance Level
- LPCN $3.25
- AEHL $6.53
- Average True Range (ATR)
- LPCN 0.19
- AEHL 0.74
- MACD
- LPCN -0.04
- AEHL -0.24
- Stochastic Oscillator
- LPCN 4.41
- AEHL 5.71
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
About AEHL Antelope Enterprise Holdings Limited
Antelope Enterprise Holdings Ltd operates in two reportable operating segments: 1) business management consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting, and 2) natural gas power generation, which was in the initial development stage. The business of the Company is engaged in the PRC and U.S.